Jm. Grichnik et al., THE SCF KIT PATHWAY PLAYS A CRITICAL ROLE IN THE CONTROL OF NORMAL HUMAN MELANOCYTE HOMEOSTASIS/, Journal of investigative dermatology, 111(2), 1998, pp. 233-238
During development, the interaction of stem cell factor (SCF) with its
receptor, KIT, is critical for the survival of melanocytes. Limited i
n vivo human studies have suggested a possible activating role of SCF
on adult human melanocytes. In order to study the impact of this pathw
ay on normal melanocyte homeostasis, human skin xenografts were treate
d with serial injections of recombinant human SCF or a KIT-inhibitory
antibody (K44.2). On histologic evaluation, SCF injection increased, w
hereas KIT inhibition decreased the number, size, and dendricity of me
lanocytes. Immunohistochemical expression of melanocyte differentiatio
n antigens, including tyrosinase-related-protein-l and gp100/pmel17, w
as markedly increased by treatment with SCF, and decreased by K44.2 tr
eatment. The number of Ki67-positive melanocytes was increased in the
SCF-treated tissue, suggesting a direct proliferative effect of SCF; c
onversely, treatment with K44.2 resulted in melanocyte loss, which did
not appear reversible with prolonged treatment. These findings demons
trate that the SCF/KIT pathway remains critical in adult human skin, a
nd that pharmacologic modulation of this single pathway can control cu
taneous melanocyte homeostasis.